Next Sequence logo

Next Sequence

North America, New York, United States, New York

Description

Next Sequence is building the largest AI factory for Biotech startups in the world.

Investor Profile

Next Sequence has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • France (50%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Biopharma
  • Generative Ai
  • Life Science
  • Machine Learning
  • Neuroscience
  • Data Center
  • Data Storage
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Next Sequence frequently co-invest with?

Drive Capital
North America, Ohio, United States, Columbus
Co-Investments: 1
Paris Business Angels
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Syntax Ventures
Africa, Lagos, Nigeria, Lagos
Co-Investments: 1
A
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Prunay
Europe, Ile-de-France, France, Louveciennes
Co-Investments: 1
Crédit Mutuel Innovation
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Blast.club
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 1

What are some of recent deals done by Next Sequence?

Biomemory

Paris, Ile-de-France, France

Biomemory leverages molecular engineering to build exabyte appliances for data centers

BiotechnologyData CenterData StorageElectronics
Series ADec 9, 2024
Amount Raised: $18,000,000
NeuroX1

Austin, Texas, United States

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Artificial Intelligence (AI)BiopharmaBiotechnologyGenerative AILife ScienceMachine LearningNeuroscience
SeedMar 3, 2023
Amount Raised: $500,000